Differences in gynecologic tumor development in Amhr2-Cre mice with KRASG12D or KRASG12V mutations

Eucharist Kun(The University of Texas MD Anderson Cancer Center), Kwong‐Kwok Wong(The University of Texas MD Anderson Cancer Center)
Scientific Reports
November 26, 2020
10.1038/s41598-020-77666-y
Cited by 12

Related Papers

BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas
|American Journal Of Pathology|2010|220
The genetic architecture and evolution of the human skeletal form
|Science|2023|79
Loss of ARID1A expression leads to sensitivity to ROS-inducing agent elesclomol in gynecologic cancer cells
|Oncotarget|2016|46
The trait specific timing of accelerated genomic change in the human lineage
|bioRxiv (Cold Spring Harbor Laboratory)|2022|5
The trait-specific timing of accelerated genomic change in the human lineage
|Cell Genomics|2025|3